Yr Athro Oliver Ottmann
Professor and Head of Haematology
Prof. Ottmann has led the development of novel drugs and highly targeted approaches, including immunotherapies and molecularly directed agents. He has served as principal investigator on numerous national and international First in Human, Phase I, II, and III clinical studies of many novel agents. His clinical and research efforts have been focused on providing therapy for patients suffering from treatment-resistant or refractory leukemia, with a special emphasis on acute lymphoblastic leukaemia and on interrogating the mechanisms of resistance to targeted therapy. He has over 250 peer-reviewed publications focused on haematology developmental therapeutics, and has particular interests in the mentoring of physician-scientists working on developmental therapeutics, as well as in developing national and international collaborations across the bioscience spectrum.
European Hematology Association, American Society of Hematology, Royal College of Pathologists
Safleoedd academaidd blaenorol
- 01/06/11 - June 2015 - Professorship of the Deutsche Jose Carreras Leukemia Foundation for Molecular Therapeutic Research at the Department of Internal Medicine, Hematology/Oncology, Johann Wolfgang Goethe University, Frankfurt, Germany
- 1999 - June 2015 - Head, Division of Molecular Therapeutics and Phase I/II Unit, Medizinische Klinik II (formerly Medizinische Klinik III), Goethe University, Frankfurt